Walleye Trading
PLXP

Walleye Trading’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Walleye Trading’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-63
Closed -$7K – 5832
2015
Q3 		$7K Buy
+63
New +$7.25K ﹤0.01% 4534

Other funds holding PLXP

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
LSVM
Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Walleye Trading's PLXP Position: Q4 2015 in Review

Walleye Trading sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2015, closing a stake of 63 shares — an estimated $7K sold.

Walleye Trading first reported a position in PLXP in Q3 2015 and held it in 1 quarter. The position peaked at $7K in Q3 2015. 29 funds tracked by Wall St. Rank hold PLXP as of Q4 2015.

  • Walleye Trading reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Walleye Trading sold 63 PLx Pharma Inc. Common Stock shares in Q4 2015, an estimated $7K.
  • Walleye Trading first reported a position in PLx Pharma Inc. Common Stock in Q3 2015 and held it in 1 quarter.
  • Walleye Trading's PLx Pharma Inc. Common Stock position peaked at $7K in Q3 2015.
  • 29 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2015.

Based on Walleye Trading's 13F filing for Q4 2015, filed 16 Feb 2016.